Chemcon Speciality Chemicals Limited – Investor Presentation Summary
Key Operational Highlights
- Quarterly revenue of ₹66.5 crore in Q1 FY27, reflecting healthy growth
- Performance driven by improved realizations across product portfolio and steady demand across key product categories
- Organic Chemicals business witnessed notable improvement driven by improved realizations across key products including HMDS, CMIC, Bromobenzene and 2-Bromo
- Inorganic Chemicals segment recorded stable performance aided by improved market conditions and improved demand year-on-year
- Manufacturing capacity of 11,400 MTPA for Organic Chemicals and 15,000 MTPA for Inorganic Chemicals
- 10 operational units, in-house R&D laboratory, and 6 owned warehouses located at Manjusar near Vadodara, Gujarat
Key drivers of operational performance: Improved realizations across key products, steady demand across several key product categories, improved market conditions for inorganic chemicals
Segment-wise Performance
- Organic chemicals (HMDS, CMIC, Bromobenzene, 2-Bromo and other ancillary products) - Performance improved notably during the quarter
- Inorganic chemicals (Range of Inorganic Bromides) - Recorded stable performance with improved demand on year-on-year basis
Explanation of significant changes in segment performance: Organic chemicals growth driven by improved realizations across key products; Inorganic chemicals growth aided by improved market conditions
Financial Highlights
Revenue: ₹66.5 crore (Q1 FY27)
EBITDA: ₹15.4 crore
PAT: ₹11.0 crore
EPS: ₹2.99
Margins: EBITDA Margin 23.2%, PAT Margin 16.5%
YoY/QoQ comparison: Revenue up 24% YoY (vs ₹53.5 crore in Q1 FY26) but down 12% QoQ (vs ₹75.4 crore in Q4 FY26); EBITDA up 98% YoY (vs ₹7.7 crore) and up 74% QoQ (vs ₹8.9 crore); PAT up 72% YoY (vs ₹6.4 crore) and up 72% QoQ (vs ₹6.4 crore)
Drivers of financial performance: Improved realizations across product portfolio, steady demand across key product categories, favorable operating environment compared to previous year
Geographical Revenue Split
Domestic vs Export Revenue:
- Export: 59% of total revenue (includes deemed exports)
- Domestic: 41% of total revenue
Balance Sheet Snapshot
Not Specified
Capex & Cash Flow Health
- Plans to add manufacturing capacity at the P-11 unit for organic chemicals
- Capital Expenditure: Not specified
- Free Cash Flow: Not specified
- Operating Cash Flow: Not specified
Investment Rationale: Capacity expansion for organic chemicals, import substitution, diversified product portfolio
Strategic & R&D Initiatives
- Capacity expansion at P-11 unit for organic chemicals manufacturing
- Import substitution strategy to capitalize on potential growth of Organic Chemicals in India
- Exploring new applications to diversify product portfolio and client base
- Cost efficiencies through process re-engineering, optimized raw material consumption, and economies of scale
- In-house R&D laboratory supporting product development
Expected impact on growth: Strengthening customer engagement across key end-user industries, sustainable and profitable growth
Strategic Rationale: Expanding into high-growth markets, reducing operational costs, diversifying product portfolio
Industry Trends & Business Environment
Macro/Industry Trends: Pricing pressure from global competition particularly imports from China persists in select products; Geopolitical developments and volatility in crude oil markets create uncertainty; Global macroeconomic conditions present uncertainties
Impact on Company: Overall operating environment remained favorable compared to previous year; Business delivered meaningful recovery over corresponding period last year
Management Commentary & Growth Outlook
Strategic Outlook: "We remain optimistic about our growth prospects, supported by improving realizations, encouraging traction across our newer product portfolio, and strengthening customer engagement across key end-user industries. While global macroeconomic conditions and geopolitical developments continue to present uncertainties, we believe our diversified product portfolio, expanding manufacturing capabilities position us well to deliver sustainable and profitable growth in the coming quarters." - Mr. Kamal Aggarwal, Chairman & Managing Director
FY Guidance: Not specified
Market Share Targets: Not specified
Risks and Opportunities: Pricing pressure from global competition particularly imports from China; Geopolitical developments and volatility in crude oil markets; Global macroeconomic uncertainties